
    
      Open label, parallel-group, single site, 5 treatment-period study with 4 dose levels of DCCR,
      1 of which is administered both with and without food, with a 10 Day washout period between
      treatments. There will be 8 treatment sequences with 4 subjects randomized to each.
    
  